Caliper Life Sciences Financial Statements
Caliper Life Sciences Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Caliper Life Sciences Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 140.7 | 107.9 | 87.0 |
| Gross Profit ($ mil.) | 66.1 | 47.3 | 38.8 |
| Operating Income ($ mil.) | (23.8) | (30.0) | (14.6) |
| Total Net Income ($ mil.) | (24.1) | (28.9) | (14.5) |
| Diluted EPS (Net Income) | (0.51) | (0.75) | (0.46) |
Caliper Life Sciences Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 34.0 | 29.3 | 40.3 |
| Gross Profit ($ mil.) | 14.1 | 11.8 | 18.3 |
| Operating Income ($ mil.) | (6.2) | (10.2) | (5.6) |
| Total Net Income ($ mil.) | (6.7) | (9.9) | (5.7) |
| Diluted EPS (Net Income) | (0.14) | (0.21) | (0.12) |
Caliper Life Sciences Stock Quote & Chart
| 09/05/08 09:54:17 EST •
NASDAQ •
2.96
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Caliper Life Sciences Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.04 | 2.12 | 1.54 |
| Price/Earnings Ratio | -- | 21.57 | 15.76 |
| Price/Book Ratio | 1.14 | 2.20 | 1.49 |
| Price/Cash Flow Ratio | -- | 15.78 | 9.63 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Caliper Life Sciences Financial Ratios
Caliper Life Sciences Competitive Intelligence
| Applied Biosystems | Beckman Coulter | PerkinElmer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 2,093.5 | 2,761.3 | 1,787.3 |
| Employees | 5,000 | 10,500 | 8,700 |
| Market Cap ($ mil.) | -- | 4,673.1 | 3,201.1 |
Competitive Landscape






